BUSINESS● LOWSep 1 · Sep 1, 2026, 3:15 AM
Small Cap Watch : XSO extends decline as Percheron funds AML trial and Nova advances US antimony plans
proactiveinvestors.com.au · Australia · north america
Small-cap stock XSO is continuing its decline as Percheron funds an AML trial and Nova progresses with its US antimony initiatives. This reflects specific company and market movements in the small-cap sector.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More from Australia
WORLD4h agoIn Australia, Sydney’s second airport blows some passengers off courseSouth China Morning PostPOLITICS4h agoAustralian minister says he is being followed after bullet etched with ‘RAT’ left on carThe Independent WorldBUSINESS6h agoJane McMillan elected to Cattle Australia board as director | The North West Starnorthweststar.com.au · AustraliaPOLITICS7h agoAustralian parliament pays tribute to Helen Haines as PM Albanese condemns increasing ‘rage and aggression’The Independent World
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESSnowOil: who between Senegal and Côte d'Ivoire will win the investment race?Jeune AfriqueBUSINESS20m agoWalmart sets holiday shopping event plansSeeking Alpha Tech